XML 58 R45.htm IDEA: XBRL DOCUMENT v3.23.2
Equity Based Compensation (Additional Information) (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Unrecognized compensation expense remaining period     2 years 2 months 12 days    
Additional compensation expense     $ 3,011,000    
Profits interests granted     0    
Share-Based Payment Arrangement, Expense $ 11,202,000 $ 8,000,000 24,222,000 $ 60,686,000  
Employee Benefits and Share-Based Compensation $ 8,440,000 8,001,000 $ 19,003,000 63,187,000  
Share-Based Payment Arrangement, Tranche One [Member]          
Weighted Average Vesting Price         $ 15
Share-Based Payment Arrangement, Tranche Two [Member]          
Weighted Average Vesting Price         20
Share-Based Payment Arrangement, Tranche Three [Member]          
Weighted Average Vesting Price         $ 25
Limited Partnership Agreement          
Profits Interest vesting description     Profits Interests awarded would vest at a rate of 25% on the latter of the first anniversary of employment and the first anniversary of the Acquisition Date with the remaining 75% to vest in increments of 25% on each anniversary following the first anniversary date, ratably over a three or four-year period from the date of grant, in annual installments of 33.3% over the three-year period from the date of grant, in increments of 6.25% each calendar quarter following the first anniversary date, or were fully vested upon issuance.    
R&D service provider [Member]          
Share-Based Payment Arrangement, Expense       14,080,000  
Profits Interest awards [Member]          
Profits Interests Issued To Service Provider $ 6.42   $ 6.09    
Unrecognized compensation expense $ 36,096,000   $ 36,096,000    
Time Vested Awards [Member]          
Unrecognized stock-based compensation expense 69,739,000   69,739,000    
Employee Benefits and Share-Based Compensation $ 4,665,000   $ 8,667,000    
Weighted Average Period 3 years 3 months 18 days   3 years 3 months 18 days    
weighted average grant date fair value $ 7.82   $ 6.7    
Aggregate intrinsic value $ 16,984,000   $ 16,984,000    
Aggregate intrinsic value exercisable 1,688,000   $ 1,688,000    
Market-Vested Awards [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares     0    
Unrecognized stock-based compensation expense 20,430,000   $ 20,430,000    
Employee Benefits and Share-Based Compensation 2,794,000   $ 5,558,000    
weighted average grant date fair value     $ 0    
Aggregate intrinsic value $ 3,130,000   $ 3,130,000    
Market-Vested Awards [Member] | Chief Executive Officer [Member]          
Number of shares, Granted     3,639,607    
Market-Vested Awards [Member] | Stock Option Awards Under Twenty Twenty Two Plan          
Weighted Average Exercise Price, Granted     $ 10.33    
Class A [Member]          
Ordinary shares reserved for issuance 35,809,951   35,809,951    
Common Class B [Member]          
Additional compensation expense   5,437,000      
Recognized compensation expense modification       3,715,000  
Previously Recognized Expense Settled Via Equity Award       2,502,000  
Share-Based Payment Arrangement, Expense   3,027,000   34,254,000  
Stock Issued During Period, Value, New Issues   $ 500,000   $ 6,050,000  
Common Class B [Member] | Limited Partnership Agreement          
Stock issued during period new shares issued   450,156   5,446,887  
Common Class B [Member] | R&D service provider [Member]          
Issuance of Class B ordinary shares to Sponsor (in shares)       2,253,033